Delivery Order SPE2DB20D3103-SPE2DB24FP4T6

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,769.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract has an ultimate completion date of August 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,437.62, is a delivery order for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.29 delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialized medication used for diabetes management. The contract has a firm fixed price pricing type and a period of performance through November 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,118.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including...
This federal contract award, valued at $5,213.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication for diabetes management. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999.00 and runs through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,327.98 fixed-price delivery order is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $98,941.00, is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 7, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,565.72 Firm Fixed Price Delivery Order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medical products. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.32 delivery order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of August 31, 2022 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $4,387.67, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medical products. The contract has an ultimate completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP4T6
    Delivery Order

This federal contract award, valued at $1,412.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of July 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:02 AM